Literature DB >> 10974062

Apoptosis: translating theory to therapy for prostate cancer.

J T Isaacs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10974062     DOI： 10.1093/jnci/92.17.1367

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Proteasomal degradation unleashes the pro-death activity of androgen receptor.

Authors:  Bradley Godfrey; Yuting Lin; Jeffery Larson; Bonnie Haferkamp; Jialing Xiang
Journal:  Cell Res       Date:  2010-05-18       Impact factor: 25.617

2.  Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.

Authors:  Imtiaz A Siddiqui; Mohammad Asim; Bilal B Hafeez; Vaqar M Adhami; Rohinton S Tarapore; Hasan Mukhtar
Journal:  FASEB J       Date:  2010-12-21       Impact factor: 5.191

Review 3.  Mechanisms of Therapeutic Resistance in Prostate Cancer.

Authors:  Mary Nakazawa; Channing Paller; Natasha Kyprianou
Journal:  Curr Oncol Rep       Date:  2017-02       Impact factor: 5.075

4.  Proteasomal regulation of caspase-8 in cancer cell apoptosis.

Authors:  Michael V Fiandalo; Steven R Schwarze; Natasha Kyprianou
Journal:  Apoptosis       Date:  2013-06       Impact factor: 4.677

5.  Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.

Authors:  Yuting Lin; Ziyan Lu; John Kokontis; Jialing Xiang
Journal:  Biochem Biophys Res Commun       Date:  2012-11-15       Impact factor: 3.575

6.  Androgen via p21 inhibits tumor necrosis factor alpha-induced JNK activation and apoptosis.

Authors:  Fangming Tang; John Kokontis; Yuting Lin; Shutsung Liao; Anning Lin; Jialing Xiang
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

7.  Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.

Authors:  Jason M D'Antonio; Donald J Vander Griend; Lizamma Antony; George Ndikuyeze; Susan L Dalrymple; Shahriar Koochekpour; John T Isaacs
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

8.  Hsp90 can accommodate the simultaneous binding of the FKBP52 and HOP proteins.

Authors:  Zacariah L Hildenbrand; Sudheer K Molugu; Nadia Herrera; Citlally Ramirez; Chuan Xiao; Ricardo A Bernal
Journal:  Oncotarget       Date:  2011 Jan-Feb

9.  Evolving perspectives of the role of novel agents in androgen-independent prostate cancer.

Authors:  Sujith Kalmadi; Derek Raghavan
Journal:  Indian J Urol       Date:  2008-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.